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Objectives: The distal basilic forearm vein is frequently preserved and might be used more frequently for placement of an
ulnar-basilic autogenous arteriovenous access (UB-AAVA) in the wrist despite the small size of the two vessels. The
scarcity of publications led us to initiate a prospective study regarding the placement and outcomes of UB-AAVAs.
Methods: Seventy patients (63 adults, seven children) with no usable cephalic vein in either forearm were selected
consecutively over 4 years for placement of a UB-AAVA. The prerequisite was a clinically visible or palpable forearm
basilic vein after placing a tourniquet. Regional anesthesia, prophylactic hemostasis, and a surgical microscope were used
systematically. Secondary superficialization was performed in two patients. Most non-matured accesses were abandoned
in favor of the placement of a more proximal autogenous access. Mean follow-up was 20 months (SD 15).
Results: Immediate patency was obtained in 94% of adults and 100% of children. Success (in-use access) was achieved in
60% of patients (38/63 adults and 6/7 children) after a mean postoperative interval of 80 days (SD 64; range, 31-277).
Failures included four immediate thromboses, one postoperative death, and 21 never-matured accesses. No steal
syndrome was observed. Initial failures included, primary patency rates in adults at 1 and 2 years were 42%  6% and
30%  7%, respectively; secondary patency rates at 1 year and 2 years were 60%  6% and 53%  7%, respectively.
Conclusions: Although patency rates are not as good as those achieved with radial cephalic-AAVA, the UB-AAVA is an
alternative autogenous forearm access before the placement of any other access involving the basilic vein. The use of the
surgical microscope is mandatory, and more than usual time is required to achieve maturation. (J Vasc Surg 2011;53:
1298-302.)
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oNative veins should be preferred over prosthetic mate-
rial for the placement of a hemodialysis access because the
long-term patency of autogenous arteriovenous accesses
(AAVA) is clearly better than that of grafts. The arterio-
venous communication should be performed as distally as
possible to preserve venous capital, since upper arm access
can compromise future placement of distal access by de-
struction of the proximal venous outflow. Furthermore,
forearm AAVA has a lower incidence of ischemia compared
with upper arm AAVA. Unfortunately, the placement of a
functional radial-cephalic arteriovenous access (RC-AAVA)
is impossible if the distal cephalic veins are destroyed.
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1298evertheless, a significant number of these patients may
ave preserved distal basilic veins, allowing placement of an
utogenous fistula between the ulnar artery and the basilic
ein in the lower third of the forearm, and the last clinical
ractice guidelines of the Society for Vascular Surgery1
tate that “when the forearm cephalic vein is not considered
dequate for an autogenous AV access, the forearm basilic
ein is the preferred alternative.”
Distal ulnar-basilic fistula (ulnar-basilic autogenous ar-
eriovenous access [UB-AAVA]) (Fig 1) is routinely cre-
ted and used in different countries, but few series have
een reported since the articles of Hanson2 (1967), Kinn-
ert3 (1977), Bourquelot4 (1990), Cetto5 (1995), and
avichandran6 (1999). The UB-AAVA can therefore be
onsidered in patients with no usable forearm cephalic vein.
nfortunately, the results of UB-AAVA are poorer com-
ared with RC-AAVA, with higher initial failure rates,
onger time to maturation, and lower patency rates. This is
robably the reason why the UB-AAVA is not mentioned
n either the Kidney Disease Outcomes Quality Initiative
K/DOQI)7 or the European guidelines.8 However, two
mall series9,10 with more encouraging results have been
ublished recently (1-year primary patency of 70%-71%).
We have been constructing UB-AAVAs for many years,
nd we are convinced that it is a valuable choice in patients
ith no usable cephalic vein in either forearm. The scarcity
f available publications and our view that, despite all the
echnical challenges, a UB-AAVA had been essential to the
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Volume 53, Number 5 Bourquelot et al 1299survival of some of our patients, led us to initiate this
prospective study on the placement and outcome of UB-
AAVA in a European dialysis population at the beginning
of the 21st century.
PATIENTS AND METHODS
Patients. This single-center prospective study in-
cluded all UB-AAVAs created in 70 patients from January
2004 to September 2009. No institutional review board
approval was required, but all patients or their parents
signed an informed consent form in agreement with the
declaration ofHelsinki. The consent of an ethics committee
is not necessary for such a nonrandomized study in our
country. The entry criteria were all patients referred for
placement of an arteriovenous access with no usable fore-
arm cephalic vein, a palpable forearm basilic vein and radial
pulse, and no need for urgent use of this new fistula. No
patient meeting the criteria for placement of the UB-AAVA
was excluded for any reason. Interventions were performed
by one surgeon in two different surgical wards. Data were
collected prospectively, together with data concerning all
vascular access placement and follow-up.
Sixty-three patients were adults, the male/female ratio
was 36/27, mean age was 54 years (range, 17-89), eight
patients were diabetic, 49 had hypertension, 22 were smok-
ers, none of them had coronary disease, and only one
patient had lower limb arterial disease. Fourteen patients
had UB-AAVA construction before initiation of dialysis,
and other patients had received previous substitutive treat-
ments for end-stage renal disease (ESRD) over a mean
period of 4.4 months (range, 0.0-13.5). UB-AAVA was the
first arteriovenous access in 16 patients, whereas the others
had received previous arteriovenous fistulas (AVFs)
(mean, 1.9; range, 1-7) and/or central venous catheters
(nine patients). Thirty-three patients had received one or
more kidney transplants (up to three in one patient) before
UB-AAVA placement.
Over the same period of time, a UB-AAVA was created
in seven children, mean age 13 years (range, 7-16) and
mean weight 33 kg (range, 9-55). Four children had pre-
viously been dialyzed for a mean period of 2.6 months.
UB-AAVA was the first arteriovenous access in all but one
child. One child had received one kidney transplant before
UB-AAVA placement.
Preoperative selection for a UB-AAVA was performed
Fig 1. Ulnar-basilic autogenous arteriovenous access. Operating
diagram.by clinical examination, associated with venography in cases chere there was history of central vein catheters. The
rerequisites were the absence of a cephalic vein in both
orearms and a clinically visible or palpable forearm basilic
ein after placing a tourniquet (except for two obese pa-
ients). The absence of stenosis and thickening of venous
alves was checked by duplex ultrasound in all patients, and
he minimum diameter of the vein was 2 mm. Patency of
he ulnar artery was confirmed, with a minimum diameter
f 1 mm. The Allen test was not considered to be a valid
ool since the fistula was constructed from the ulnar and not
he radial artery. Arterial calcification did not preclude an
ttempt at fistula placement, although it was likely to render
he construction of an anastomosis more challenging.
Surgery (Fig 2). All interventions were performed
nder regional anesthesia. Preventive hemostasis was
chieved by the application of an Esmarch elastic bandage
ollowed by the placing of an inflatable tourniquet.11 A
ongitudinal incision was made in the medial aspect of the
rist. For the dissection of the lower part of the forearm
asilic vein, which was performed with the help of magni-
ying glasses, it was helpful to place the elbow in flexion
osition. After section of the vein above a ligature, a longi-
udinal posterior incision of approximately 10 mm in
ength was made in the proximal vein. The flexor carpi
lnaris was frequently partially resected to expose the ante-
ior aspect of the distal ulnar artery. Preventive hemostasis
enders extensive dissection of the artery and clamping
with the risk of arterial spasm) unnecessary. When prophy-
actic hemostasis was inefficient, microclamps were placed
n the artery after minimal dissection. It was then necessary
o return to elbow extension and forearm supination for
ig 2. Operating view (right forearm). 1, ulnar artery and veins;
, flexor carpi ulnaris (resected); 3, ulnar nerve; and 4, basilic vein.onstruction of the side-to-end anastomosis using Ethilon
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May 20111300 Bourquelot et al9/0 monofilament sutures (Ethicon, Auneau, France) and
the OPMI Vario/S88 System surgical microscope (Zeiss,
Le Pecq, France).12-15 If there was any doubt, an intraop-
erative Doppler examination (permanent signal with sys-
tolic reinforcement) was used as an indicator of immediate
patency. Second-stage superficialization was performed
successfully in two obese patients, including one transposi-
tion to the volar aspect of the forearm, with a new anasto-
mosis to the radial artery at 3 months and one lipectomy
limited to the upper forearm at 12 months.16
All fistulas were checked clinically by the surgeon at 2
months in combination with duplex ultrasound examina-
tion. Juxta-anastomosis stenoses were treated by surgical
reanastomosis.
Statistical analysis. Technical success was defined as
immediate postoperative patency of the fistula checked by
clinical examination (thrill). Clinical success was defined by
the performance of at least one successful dialysis session
through the UB-AAVA (Fig 3).
Patency rates after UB-AAVA placement were calcu-
lated according to the Life Tablemethod using the SPSS 18
program, in agreement with the recommended reporting
standards of the Society for Vascular Surgery.17,18
Primary patency was defined as the interval from the
time of UB-AAVA placement until any intervention de-
Fig 3. Mature ulnar-basilic autogenous arteriovenous access.signed to maintain or reestablish patency, access thrombo- ris, or the time of measurement of patency or access aban-
onment. A UB-AAVA, which was not mature (unusable)
ithin 6 months, was abandoned. Secondary patency was
he interval from the time of UB-AAVA placement until
ccess abandonment, or the time of patency measurement,
ncluding intervening manipulations (surgical or endovas-
ular interventions) designed to maintain or reestablish
unctionality in dysfunctional or thrombosed accesses.
ESULTS
Immediate technical success was achieved in 59/63
dult patients (94%) and in 7/7 children. The four imme-
iate failures were related to previously unrecognized le-
ions of the two vessels: two heavily calcified and stenosed
lnar arteries and two high-grade and extensive venous
esions. One unrelated postoperative death was the only
evere early complication (30 days).
Clinical success was achieved in 60% of patients (38/63
dults and 6/7 children) at a mean postoperative interval of
0 days (SD  64; range, 31-277). Clinical failures (in
ddition to the postoperative death) included the four
echnical failures and 21 fistulas (20 adults and one child),
hich were never usable for dialysis, 20 because of non-
aturation related to poor venous or arterial condition and
ne because of upper limb edema due to central vein
tenosis not accessible to percutaneous transluminal angio-
lasty (PTA). Most of the non-matured fistulas were aban-
oned in favor of the placement of a more proximal fistula,
nd only a few cases were treated by PTA. No patient
omplained of any debility resulting from the division of
he flexor carpi ulnaris. Mean follow-up was 20 months
SD  15).
Doppler flowmeasurement was available at 6months in
4 patients with functional UB-AAVA, and the mean flow
ate was 644 mL/min (range, 300-1300).
Nine adults died during follow-up, 11 patients were
ransplanted, six previous functional accesses were aban-
oned because of secondary nonrecoverable thrombosis
nd one access was ligated for arm edema caused by central
ein stenosis related to pace-maker wires. Surgical revision
f the anastomosis was performed in nine patients, 10
ccesses underwent at least one PTA, two thrombosed
ccesses were successfully recovered (one by surgery, one
y interventional radiology), one access required aneurys-
orrhaphy, and one required urgent intervention for skin
ecrosis at the puncture point. No steal syndrome oc-
urred.
Adult primary patency rates (Fig 4) at 1 and 2 years
ere 42% 6% and 30% 7%, respectively, and secondary
atency rates at 1 year and 2 years were 60%  6% and
3%  7%, respectively. The statistics for children have no
eal value in view of the small number of patients. Primary
nd secondary patency rates at 1 year were 17% 11% and
7%  16%, respectively.
ISCUSSION
Patency rates. UB-AAVA patency rates were compa-
able to those observed with RC-AAVA, with poorer early
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patency rates with time compared with any other type of
access.
Our 1-year primary patency rate of 42% (immediate
failures included) is in agreement with the results of Cetto
but appears lower than those reported by Kinnaert (61%),
Salgado (71%), and Weyde (70%).3-9,10 However, some of
these retrospective studies seem to have calculated the
patency rates after exclusion of the immediate failures. In
addition, none of them provided the diameters of arteries
and veins before surgery. It can be hypothesized that these
colleagues were more demanding regarding the basic qual-
ity of vessels since they never mentioned the problem of
delayed maturation.
Our secondary patency rates of 60% and 53% at 1 and 2
years are disappointing butmight be improved in the future
by a more aggressive attitude to non-maturing UB-AAVA
using endovascular techniques. Natário recently reported
excellent secondary patency rates (97% at 1 year) after
dilation of nonmaturing UB-AAVAs despite poor primary
patency rates (37% at 1 year).19
Advantages. The advantages of the UB-AAVA are
those of autogenous vascular accesses: native vessels are less
prone to infection and develop fewer complications, with a
particularly low risk of thrombosis once matured. In addi-
tion, the location in the forearm preserves the possibility of
upper arm accesses in the future and is associated with lower
risk of hand ischemia or excessively high flow access. The
very low incidence of hand ischemia deserves to be empha-
sized, especially in view of the high rates reported with
elbow accesses. A recent prospective study pointed out that
Fig 4. Primary (______) and secondary (- - - -) patency rates after
autogenous arteriovenous access placement in adults according to
the Life Table method and numbers of patients at risk (N) and
standard errors (SE) at the start of each interval.28% of elbow accesses developed symptoms of ischemia, bhile 11% needed intervention for severe symptoms within
year after access placement.20 The small ulnar artery is
uch less likely to develop excessive access flow with time
han the brachial or even the radial artery. This is a signifi-
ant argument in favor of forearm AAVA in view of Basile’s
ecent publication reporting an increased risk of cardiac
ailure in patients with access flow above 2 L/min.21
Drawbacks. The small diameter of the ulnar artery
nd wrist basilic vein compared with the radial artery and
istal cephalic vein at the same level increases the technical
hallenge in the placement of the anastomosis. Our expe-
ience with microsurgery, which has allowed the placement
f successful anastomoses even in cases of small-diameter
rteries and veins in children, led us to perform this tech-
ique in adults. Nevertheless, the use of the smaller ulnar
nd distal basilic vessels probably explains the significant
roportion of delayed maturation in our series. The 80-day
ean time to maturation is clearly longer than the 6 weeks
dvocated by the DOQI Guidelines7 for RC-AAVAs.
The initial dialysis cannulations may be slightly chal-
enging because of the mobility of the vein, especially in
ountries where cannulation is not mandatorily performed
y dedicated nurses. The posterior location of the vein is
he main reason why the basilic veins are often the only
reserved veins in both forearms. Cannulation of the fore-
rm basilic vein after arterialization requires placing the
imb in the flexed-elbow position, which is uncomfortable
or many nurses and patients. However, the elbow can
eturn to its natural resting position for the duration of
ialysis treatment once access has been gained and needles
ecured to the skin.
Strategy. One key point is to determine the place of
he UB-AAVA in the currently recommended algorithms
or access placement. It is clear that the RC-AAVA remains
he access of choice. It is easier to construct, since the radial
rtery and the forearm cephalic vein are larger than the
lnar artery and basilic vein. However, when no RC-AAVA
an be created, we believe that the placement of an
B-AAVA should be systematically contemplated before
he placement of an autogenous brachial-cephalic AAVA
BC-AAVA), which comes second after the RC-AAVA in
he current recommendations. Anatomic prerequisites in-
lude a clinically palpable forearm basilic vein and radial
ulse, the absence of outflow stenosis at duplex ultrasound,
ith a minimum diameter of 2 mm for the vein, and 1 mm
or the ulnar artery. However, the usually longer matura-
ion time and the significant risk of initial surgical failures of
he UB-AAVA should be taken into account.
In predialysis patients, the UB-AAVA might be pre-
erred over a BC-AAVA whenever the scheduled date for
nitiation of dialysis leaves sufficient time for maturation of
he UB-AAVA or placement of a new access in cases of early
ailure of the UB-AAVA. In patients currently dialyzed via
temporary central line, the BC-AAVA might be preferred
o shorten the need for this undesirable central catheter. A
B-AAVA can also be considered when an ipsilateral
rachial-cephalic fistula or any contralateral access needs
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predictable abandonment.
If placement of a UB-AAVA is to be considered in the
future for a patient, then this should precede placement of
a brachial-basilic AAVA or graft, as placement of the latter
precludes placement of the former.
Technical refinements. From a technical point of
view, our opinion is that the placement of the UB-AAVA is
better performed using a surgical microscope and an inflat-
able tourniquet. The ulnar artery is usually clearly smaller
than the radial artery, and the basilic vein at the wrist is
smaller than the cephalic vein. The construction of the
anastomosis between such small vessels can be challenging,
and previous publications regarding children have empha-
sized the value of the microscope in such cases. In the
present series, except for juxta-anastomosis stenoses treated
by placement of a slightly more proximal anastomosis,
secondary stenoses were corrected by interventional radiol-
ogy, with technical difficulties and results comparable to
those of RC-AAVAs, and this might explain our better
secondary patency rates compared with previously pub-
lished series.
CONCLUSIONS
Although patency rates are not as good as those
achieved with RC-AAVAs, when an RC-AAVA cannot be
created, and before the placement of any other access
involving the basilic vein, the UB-AAVA is an alternative
AAVA which, once matured, shares the advantages of fore-
arm AAVAs compared with upper arm AAVAs and grafts.
The placement of a UB-AAVA is technically challenging,
and the use of a surgical microscope helps to overcome the
surgical difficulties related to the small size of the vessels.
However, maturation may be slow and low maturation
rates are common.
The authors especially thank Pascal Delacou for assis-
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(translator) for revision of the manuscript.
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